Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort
D. Byng (Munich, Germany), J. Lutter (Munich, Germany), R. Holle (Munich, Germany), R. JöRres (Munich, Germany), A. Karch (Hannover, Germany), S. Karrasch (Munich, Germany), H. Schulz (Munich, Germany), C. Vogelmeier (Marburg, Germany), M. Wacker (Munich, Germany)
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Byng (Munich, Germany), J. Lutter (Munich, Germany), R. Holle (Munich, Germany), R. JöRres (Munich, Germany), A. Karch (Hannover, Germany), S. Karrasch (Munich, Germany), H. Schulz (Munich, Germany), C. Vogelmeier (Marburg, Germany), M. Wacker (Munich, Germany). Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort. 3152
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study Source: Eur Respir J, 55 (5) 1901139; 10.1183/13993003.01139-2019 Year: 2020
Pre-post evaluation of healthcare resource utilization (HCRU) among patients with COPD enrolled in a digital health intervention. Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine Year: 2021
Intensive care results and costs of advanced age patients with respiratory failure: 3 years cohort study Source: Annual Congress 2011 - Intensive care outcome Year: 2011
Direct cost analysis of COPD patients: A 1 year follow-up study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016
Incidence and impact of healthcare defined exacerbation amongst a cohort of primary care COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 89s Year: 2004
Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET Source: ERJ Open Res, 7 (3) 00242-2021; 10.1183/23120541.00242-2021 Year: 2021
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study Source: Eur Respir J, 49 (5) 1602114; 10.1183/13993003.02114-2016 Year: 2017
Trends and predictors of asthma costs: results from a 10-year longitudinal study Source: Eur Respir J 2016; 47: 801-809 Year: 2016
Epidemiological study to assess the quality of life and health care resource utilization by patients with mild COPD (EPIDEPOC) Source: Eur Respir J 2005; 26: Suppl. 49, 514s Year: 2005
The economic burden of COPD in a Swedish cohort: The ARCTIC study Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Predictors of mortality in cancer patients requiring intensive care support: Two-centered cohort study Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
COPD management in general practice –One year follow-up of the Swiss COPD cohort study Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
A time-limited, six month program of community-based disease management, support and education following hospital admission for AECOPD: Outcomes from a pilot study Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Two-years of a community maintenance follow-up program in patients with COPD Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012